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tively. 85% of baseline pathogens were eradicated in patients treated 
with either azithromycin or clarithromycin. By day 28, all 47 evalu- 
able azithrotnycin-treated patients had been successfully treated, 
compared with 46/49 (94%) who received clarithromycin. All base- 
line pathogens were eradicated from evaluable patients in the 
azithromycin treatment group, but only 83% of those in patients who 
received clarithromycin. Treatment-related adverse events were 
reported in 10 (14%) azithroniycin patients, and 11 (16%) who 
received clarithromycin. These were mainly gastrointestinal, and mild 
to moderate in intensity. One clarithromycin patient mscontinued 
treatment due to an adverse event. 
Conclusions: Three-day once-daily azithroniycin is as effective 
and well tolerated as 10-day clarithromycin given twice daily in adults 
with community-acquired pneumonia. 
Lp2721 Meropenem versus imipenem/cilastatin in the 
treatment of community-acquired pneumonia 
in elderly patients 
A. Pozzi, P. Cravarezza, L. Sleiman, P. Donati, P. Prometti, M.C 
Tusi, G. Ravizzola, L. Franchino, G. Romanelli. Departments vf 
Internal Medicine G Microbiology, University vf Bvescia, ltaiy 
Objectives and methods: In an open, randomized (ratio 1:l). 
prospective study the clinical and bacteriologic efficacy and safety of 
nieropenem (MEM) was assessed and compared with that of 
iiiiipenem/cilastatin (IMP/CIL) in 97 hospitalized elderly patients 
(pts) (41 M, 56 F, age range 68-92 years) with community-acqulred 
pneumonia (CAP). Clinical and bacteriologic responses were assessed 
at the end of therapy and at follow-up ( 2 4  weeks). 48 pts received 
MEM (500 mg t i d .  IV) and 49 pts IMP/CIL (500 mg t.i.d. IV). 
Results: In 82 cases (40 in the MEM group and 42 in the 
IMP/CIL group) causative germs were isolated: 38 Gram positive 
(Staphylococcus aureus 12 cases, Streptococcus pneumonia 26) and 44 Gram 
negative (Haernoplzilus spp. 15 cases, Pwudomonas aenrfinosa 6, 
Klebriella pnrumoniar 11, Escherickia cofi 4, Moraxella catarukalis 8). At 
the end of therapy both groups of pts had highly satisfactory clinical 
responses (92% MEM, 89% IMP1CIL). High rates of cure or 
improvement were also seen at the 2-4-week follow-up in both 
groups (90% MEM, 86% IMP/CIL). The mean total cost of thera- 
peutic antibiotic administration for each pt was $1655?141 in the 
MEM group and $1 8742 172 in the IMP/CIL group. Both agents 
showed good activity in microbiologicalal assessments against Gram- 
negative and Gram-positive pathogens. More pts treated with MEM 
(90%) achieved a satisfactory bacteriologic response than pts treated 
with INT/CIL (86%). The difference in favor of MEM (86% versus 
80%) was also observed a t  the 2-4-week follow-up. The drugs were 
well tolerated and side effects occurred in 3% of cases. 
Conclusions: This study shows that MEM is an effective and 
well-tolerated drug and is as effective as IMP/CIL in the treatment 
of CAP. 
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(p273( Hepatic infection markers in HIV-infected IDUs 
in Russia 
M. Bobkova, N. Detkova, E. Buravtsova, V. Pokrovsky. Russian 
AIDS Center, Moscow, Russia 
Objectives: To refine the data on the prevalence of hepatitis B and 
C among HIV-infected intravenous drug users in Russia. 
Methods: The sera from 262 HIV-infected IDUs (mostly asymp- 
tomatic with regard to HIV and hepatic infections, age group 18-25, 
drug use duration 0.5-2 years) collected in Tver, Kaliningrad, 
Rostov, Nizhny Novgorod and Krasnodar were analyzed by EIA for 
the presence of antibodies to HCcAg, HBcAg, HbcAg, as well as 
HBsAg, HfleAg and HCV RNA. 
Results: The figures obtained are presented in the table. No 
samples of59 PCR analyzed were revealed as HCV positive by HCV 
KT-PCR only. 97.8% of sera were found positive by a t  least one 
hepatitis marker, either HBV or HCV No samplet were negative 
in all tests simultaneously. 65.7% (621106) of patients had mixed 
infection with both HCV and HBV (at least one iiiarker of e ~ c h  
hepatitis). 
\Marker\ anti t HCV 1 anti \ anti 1 H B S h  JHBeAzl 
Conclusions: Widespread hepatic viral infections as well as the 
extremely high percentage of mixed infections are of principdl inter- 
est. The prevalence ofearly hepatitis markcrs in IDUs may result from 
the short duration of drug usage. The most striking fact is thc alnmst 
total absence of hepatitis-free IDUs. This fact must be taken into 
account when designing the course of therapy for these patients. 
lp2741 Pneumonitis in patients infected with HIV in 
the protease inhibitors era: a survey in a 
northeastern Italian area 
M. Libanore, E. Prim, M. Marino, S. Bontempell~, M.K. Rossi, F. 
Ghinelli. Departments vflnfertious Diseasa and Micdio/o'q~ St A r m  
Huspiral, Ferrara, ltaly 
Objectives: To evaluate the incidence of pneumonia in HIV-poai- 
tive patients admitted to a hospital in northeastern Italy. 
Methods: All HIV-positive patients hospitalized in our depart- 
ment from January 1997 to August 1998 were analyzed fix the kind 
of pneumonia, age, gender, HIV rlsk factor, prophylaxis, C114 
Iyniphocyte count, culture and direct examination of sputum and 
blood specimens. Clinical symptoms, chest X-ray, antiretroviral ther- 
apy and clinical outcome were evaluated for each patient. 
Results: O f  the 152 HIV-pocitive patients hospitalized, 56 
(36.8%) came to our attention because ofpneumonia; 40 were inales 
and 16 females (mean age 40.7 years, range 26-85); 37 drug addicts, 
15 heterosexuals, 3 homosexuals and 1 hemophlliac; 18 patients had 
full-blown AIDS (32.1%). The mean count of CD4 cells was 
103.6/mm'. The etiology of pneumonia was: general bacteria in 31 
patients (55.3%), J? (arinii in 12 patients (21.4%), M.  pneunro,liae in 9 
patients (16.1%), atypical mycobacteriosir in 7 patients (12.5%), M.  
tnbercrrlosis in 3 patients (5.3%), Asperfillus spp. in 2 patients (3.h'%)), 
cytomegalovirus in 2 patients (3.6%), and L. pneumoplda and nL: aster- 
oidrs in 1 patient (1.8%)). 10 patients displayed multiple simultaneous 
infections. Patients with PCP had a mean CU4 ccll count of 
36.6/mm3 (range 1-103), and patients with bacterial pncunionia had 
99.3/1nm' (range 1-1122). 11 cases were AIDS: 10 for PCI' and 1 
for tuberculosis. At admission, 17.8% of the patients had received 
anti-PCP prophylaxis and 32.1% were already under antiretroviral 
therapy: 11/18 under triple therapy two nucleoside anaIoR and one 
protease inhibitor), 3/18 with the combination of two nucleoside 
analogs, and 4/18 with single therapy (3 AZT and 1 114T). The inci- 
dence of symptoms In the considered patients was: fever 92.8?4, 
productive cough 38.5%, unproductive cough 7.496, dyspnea 39.3'%1, 
chect pain 25%, cyanosis 8.9%, and hemoptysis 3.6%. 30.3'%1 of the 
patients died during hospitalization 
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Conclusions: In our area the incidence of hospitalization for 
pneumonia has decreased, as also observed for other HIV-related 
pathologies, most likely due to antiretroviral therapy. PCP and tuber- 
culosis were mainly observed in occulted AIDS. Bacterial pneumo- 
nia represents the most frequent cause of hospitalization among 
pulmonary pathology, followed by pneumocystosis; nevertheless, the 
infections due to intracellular pathogens (Mycoplasma, hgionella, 
Norardia spp.) are increasing. 
Characteristics of the patients tested for HIV in 
the Anonymous Clinic 
Z. Zilius. Kaunas District Hospital of Injectious Diseases, Kaunas 
Lithuania 
Objectives: To find out the age, sex, and reasons why patients 
applied to the Anonymous Clinic of Kaunas District Hospital of 
Infectious Diseases for HIV testing. 
Methods: Patients who voluntarily applied to the Anonymous 
Clinic were questioned, examined and tested for HIV and STDs. 
Results: From January to September 1998, 180 patients visited 
the Clinic for HIV testing; 118 (66%) of them were male, 62 (34%) 
female. The answers to the questions of what their motives were for 
applying to the Clinic were as follows: 95 (53%) health disorders, 59 
(33%) chance sex, 20 (1 1%) suspected partner infidelity, and 6 (3%) 
AIDS phobia. 39 had once taken an HIV test (result negative). 24 
had had an STD before. One case of HIV infection was detected, 
and 25 had other STDs (5 of them syphilis). For ages of patients see 
the table: 
A@ I < m  120-24 I 25-29 I 3034 I 35-39 1 r39 
P&nra! 10 1 36 I 55 I 33 I 25 I 21 
Conclusions: There are more than 120 diagnosed HIV-positive 
patients in Lithuania at pre5ent. Half of them are younger than 25 
years. Only 23% of the patients who applied to our Clinic for HIV 
testing are younger than 25 years. Therefore it is to be supposed that 
healthcare workers must pay more attention to sexual education for 
young people and HIV prevention problems in the Kaunas region. 
lP2761 First case of Enterocytozoon bieneusi infection 
in the Slovak Republic 
L. Cislikovi’, I .  Schrhtet, P. Jarcuska’. ‘Department cf Epidemiologx 
’Clinic cf &fectoloa, Faculty of Mediciiw, Kosice, Slovak Republic 
Objectives: Microsporidia are increasingly recognized as oppor- 
tunistic pathogens in HIV-infected patients. In view of the increas- 
ing number of cases of human microsporidiosis. Enterocytozoon 
bieneusi has been reported with increasing frequency in HIV-infected 
patients with chronic diarrhea. 
Methods and results: The first case of enterocytozoonosis was 
detected in August 1997. The authors describe a case of a 41-year- 
old patient with AIDS in whom microsporidian spores of 
Enterocytozoon bieneusi were detected in the stool using optical bright- 
ener Rylux BA (Ostacolor, Pardubice, Czech Republic). 
Conclusions: In view of the fact that the number of HIV-posi- 
tive patients is on the increase in the Slovak Republic, it will he 
necessary to pay due attention to microsporidial infections. 
Supported by VEGA grant 1/5005/98. 
lw] Modification of the etiology of the pulmonary 
diseases in HIV-infected patients in Russia 
0. Yurin’, N. Makaroval’, A. Kravchenko’, B. Gruzdev’, N. 
Burova’, VY. Pokrovsky‘. ’Russia A I D S  Federal Center, Moscow, 
2Moscow Municipal Infectious Hospital N2, ‘Federal Infectious Hospital, 
St Peterburg Russia 
Objectives: To estimate the modification of the etiology of 
pulmonary diseases in HIV-infected patients in Russia. 
Methods: The comparison of the structure of the pulmonary 
diseases of HIV- infected adults in Russia, before 1994 and from 
Results: The etiology of the pulmonary diseases is presented in 
1994-97. 
the table below. 
P Man1994 -1994 
# % m y .  M 
14 48.3 32 52.5 W.05 
8 27.6 I 1.6 s0.M 
3 10.3 13 21.3 < O M  
S 10.3 4 6.6 M.05 
0 0 6 9.8 W.05 
I 3.5 I 1.6 W.05 
0 0 4 6.6 M.05 
29 LOO 61 100 
Conclusions: We found a decrease in fungal diseases and an 
increase in tuberculosis and CMV lesions (as a tendency). The 
decrease in pulmonary fungal disorders was caused by the introduc- 
tion of the antifungal prophylactic fluconazole, which was started in 
1993 at 0.15 g once a week for HIV patients who had candidial infec- 
tions after the full course of treatment. 
lp278( Disseminated Mycobecterium avium complex 
(MAC) infection in HIV-infected Spanish 
children 
M. De Jose, F. Baquero. n l e  Spanish Pediatric-AIDS Collaborative 
Group, Hospital Infawtil la Par, Enfrmedades Infcciosas, Madrid, Spain 
Objectives: To determine the prevalence, clinical course, laboratory 
findmgs, treatment and outcome of MAC infection in HIV-infected 
Spanish children and to correlate CD4 cell counts with the moment 
of appearance of the infection. 
Methods: The medical records of HIV-infected children younger 
than 15 years of age with proven MAC infection in 12 large pedi- 
atric hospitals during a 12-year period (1986-97) were retrospectively 
reviewed. 
Results: A total of 19 disseminated MAC infections were diag- 
nosed among 879 HIV-infected children (2.2%). There were 10 boys 
and 9 girls. Median age was 6.4 years (range 2.5-1 1 years). The stage 
of HIV infection was C3 in all cases. Nine children had previous 
history of opportunistic infections (5 crytosporidiosis, 2 esophageal 
candidiasis, 1 PCP pneumonia, 1 disseminated tuberculosis). MAC 
was isolated from blood (6), visceral lymph nodes (6). bone marrow 
(5), liver biopsy (2) and pleural fluid (1). Additionally, MAC was 
isolated from gastric aspirates (7)  and sputum (1). Prior to diagnosis, 
all patients presented persistent fever (35 8iplusmn; 25 days), 
anorexia, malaize and severe failure to thrive (weight <P3); nine, 
chronic-diarrhea (39 Biplusnin; 26 days), and four severe abdominal 
pain. Ten children had hepatosplenomegaly with mild elevation of 
aminotransferases. Enlargement of visceral lymph nodes was found in 
10 cases (6 abdominal, 4 mediastmal). AU patients were severely 
immunosuppressed, with a median CD4 percentage of 5% (range 
G15) and median CD4 cell count of 34 cells/mL (range 0-108). 
Fifteen children died, with an average survival period of 6.5 months 
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(range 0.1-23), and four remained alive after 24 (2), 8 and 6 months 
of therapy. 
Conclusions: Disseminated MAC infection is an unusual event 
aniong Spanish HIV-infected children. Diagnosis was reached late 
after appearance of sympton~s. The infection occurred in advanced 
patients with very low CD4 counts. 
m1 Clostridium difficbassociated diarrhea and 
HIV infection in the HAART era 
K. de Gaetano Donati, M. Tumbarello, E. Tacconelli, S. 
Bertagnolio, E Leone, R. Cauda. Departments of It+ctious Disease 
and Microhiolog)!, Catholic University, Rome, Italy 
Objectives: To verify the impact, if any, of highly active antiretro- 
viral therapy (HAART), with use of a triple combination therapy of 
one protease inhibitor and two nucleoside reverse-transcriptase 
inhibitors, on Clostridiirm d!@fFcile-associated diarrhea (CDAD) in 
patients with HIV infection. 
Methods: We have evaluated the incidence of CDAD in two 
periods: prior to (period A: January 1995 to June 1996) and after 
(period B: January 1997 to June 1998) the introduction of HAART. 
Since HAART became the standard therapy for HIV-infected 
patients in September 1996 in Italy, we have not included the cases 
of CDAD that occuri-ed in the second semester of 1996. 
Results: We observed 32 episodes of CDAD in period A and 17 
in period B. By comparing the incidence of CDAD in periods A and 
B, a statistically significant difference in the incidence ofCDAD, from 
4.7% to 2.4%, was observed (P=0.03; RK=1.94; 05% 
C l =  1.03-3.68). Interestingly, the analysis of risk factors of CDAD 
did not significantly differ in the two study periods and it was in line 
with our previous observations. 
Conclusions: The significant reduction of CDAD in HIV- 
infected patients under HAART is not only the effect of the immune 
restoration, as witnessed by the increase in peripheral CD4+ cells, 
but probably also of the reduced exposure to C. dtjicilr due to the 
drop in hospitalization, and to the consequent reduced use of broad- 
spectrum antibiotics, both well-known risk factors for CDAD 
[-I Increasing incidence of hepatitis C (HCV) and 
human immunodeficiency virus (HIVI-HCV co- 
infection. Significance for the future 
A. Gupta, K. Tate, M. Saquib, M. Hoffiiian-Terry Leh$? Valley 
Hospital, Allentown, PA, USA 
Objectives: To study the incidences of HCV and HIV-HCV co- 
infection in a mixed patient population and its future significance. 
Earlier reports with mixed results. 
Methods: A retrospective study was conducted where patients’ 
charts, computer records and activity ofice records were analyzed for 
the period July 1995 to June 1998 for HCV and January 1996 to June 
1998 for the co-infection. Results of the HCV screen and titers were 
analyzed in relation to the total number of patients, new patients and 
number of HCV tests ordered. Relevant literature was reviewed. 
Results: H C V  
Jul-Dee95 Jan-Jun96 Jul-Dee96 JauJun97 Jul-Dec97 Jan-Jun98 
HCV+ 20 35 52 154 225 352 
No.Tested 150 225 215 625 750 900 
Ye + 13.3 15.5 18.9 24.6 30.0 39.0 
Table-2: HCV-HIV Co-Infection: 
JanJun96 Jul-Dec96 JanJun97 Jul-Dec97 JanJnn98 
H C V + W +  3 1 1  15 19 25 
New Patients 41 64 58 43 51 
% + 7.3 17.1 25.8 44.1 49.0 
Conclusions: The incidences of HCV dnd HCV-HIV co-infec- 
tion have been steadily increasing over the last few years. THs could 
be due to: increased awareness, better diagnostic technology, testing 
more patients, etc. We need to distinguish between acute and chronic 
stages. HCV may be an invisible epidemic ready to explode. We 
know little about HCV-HIV co-iiifcction and this needs more 
exploration. For the future we need to concentrate on education, 
prevention of risk factors, effect on HIV-positive patients, quality of 
life, treatinent trials, liver functions, etc. 
Lp2811 Influence of co-infection with hepatitis viruses 
on antiretroviral-induced hepatotoxicity in HIV- 
infected patients 
E. Negredo, I? Doiiiingo, M.A. Sambeat, J.M. Guardiola, J. Ris ,  G. 
Vazquez. Hospital de la Sanfa Creu i Sant Pau, Barcelona, Spaiti 
Objectives: To deterniine the influence of co-infection with hepati- 
tis B and/or C. viruses (HDV/HCV) on aiitiretroviral-induced hcpa- 
totoxicity in HIV-infected patients. 
Methods: Liver functions (GOT, GPT, alkaline phosphatase, 
GGT and bilirubin) of 45 HIV-infected patients, baseline and after 6 
months after introduction of antiretroviral drugs, were andyzed; 32 
ofthenm had a follow-up of 12 months. Hepatitis virus serologic status 
was known for all patients. Multiple ANOVA was used for analysis. 
Results: Fortyfive HIV-infected patients, 38 men and 7 women, 
were studied. Thirtyseven patients (82.2%) started anriretroviral 
therapy with three drugs containing indinavir (78.3%1), ritonavir 
(16.2%) or nevirapiiie (S.4%), and 8 (17.8’%,) with two drugs. Twcnty- 
two patients (48.9%)) were HBV and/or HCV positives and 23 
(51 .l%) seronegatives. After introduction of therapy, GOT, GPT, 
alkaline phosphatase and GGT evolution between patients with o r  
without serologic evidence of hepatitis virus infection were similar, 
but a significant increase in bilirubin was detected 01: 0.016 after 6 
months; 11: 0.023 after 12 months). 
Conclusions: In our group of patients hepatotoxicity after intro- 
duction of antiretroviral therapy was similar in those co-infected or  
not with hepatitis viruses. Only a significant increase in bilirubin was 
seen, probably because most of these patients were on indinavir- 
containing regimens. 
1p2821 Influence of co-infection with hepatitis B and C 
viruses /HBV/HCV) and VIH-1 on VIH-1 viral 
load (VL) 
E. Negredo, €? Doiiiingo, M.A. Sambeat, J.M. Chardiola, J. Kis, J. 
Cadafalch, M. Fiister, N. Margall, G. Vazquez. Hc>syifal Sant Paw, 
Bavceloria, Spaiii 
Objectives: To study the influence of co-infection with HBVIHCV 
on HIV-1 VL. 
Methods: One hundred and ten antiretroviral-naive HIV-infected 
patients were tested for HBV (ELISA) and HCV (ELISA/RIBA). 
HIV-1 VL was determined by reverse transcriptate PCK in all of 
them. They were classified according to the 1993 C I X  staging 
system and subclassified depending on hepatitis virus serologic status: 
group I: VHB/VHC negatives; group 11: VHC positives; group Ill: 
VHB/VHC positives. Statistical analysis: Statview 4.5. 
Results: 71 men and 39 women, mean age of 35.0 2 7  .O years. 
57% intravenous drug users, 26% heterosexual and 17% homosexual. 
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T& 1 Virologicsl and imu~olosical faturn. 
N (Jc) VL ClW(nUnl) 6 1  GI1 0111 
STAGEA 63(56) 161461f32649* 548f302 22 28 I2 
STAGEU I R ( 1 7 )  411296i121581' 233i IS2 4 9  5 
SI'AGEC 30(27) 662287+184411* 163f188 16 10 4 
*S(Mdudamr ofthernun 
Tabla 2. Vinl lord of d i E W  pups.  
W.GHOUP I V L G R V ~ I P  II vLcnouP111 P 
SrAGEA lOS868i33OlI 148572f4ZIS7 328884f 123T77 0,06'/O,u3" 
STAGE H 106674 f44509 305413f 177477 845184 f 202053 0.016' 
SI'AGEC 443875fX14Y 458055f123613 2046512f1217045 O,WI* 
*rmmas bm .II -; **nlirmm- bawem - I 111 
Conclusions: Co-infection with hepatitis viruses increased HIV- 
VL in antiretroviral-naive patients and it could be a negative prog- 
nostic factor for HIV infection 
lp2831 Kaposi sarcoma-an uncommon clinical 
presentation 
A. Graca, G. Carmo, M.L. Arahjo, M.A. Norberto. Servico de 
Doencas Infecciosas, Hospital de Sanca Maria, Lisboa, Portugal 
Epidemic kaposi sarcoma (KS) is a clinical entity well known today, 
characterized by clinical and epidemiologic elements, namely the 
association with the acquired iniunodeficiency syndrome (AIDS), 
inale homosexuality and the hunian herpesvirus 8, a recently 
described transmissible agent. 
The diagnosis of the disease is generally not dificult, because it 
appears in a specific epidemiologic context, and it is characterized by 
specific skin lesions that can be confirmed by skin biopsy. 
In the case reported-a white male, 24-year-old, intravenous drug 
using, non-homosexual patient who appeared with fever and 
progressive weight loss for 1 month, splenomegaly and generalized 
lymphadenopathy, initially without skin lesions-the diagnosis of KS 
was made by lymph node biopsy. Some days after admission some 
characteristic skin lesions appeared. The response to liposomal 
doxorubicin treatment was excellent, with weight gain, disappear- 
ance of fever, and reduction of lymphadenopathy and skin lesions. 
Given the rarity of the situation, the authors believe that it merits 
being reported, in order that other similar situations may be more 
easilv identified in the future. 
lp2841 HIV seropositivity strikes a new high in the 
pink city-Jaipur 
AS. Guleri, K. Saxena, R.K. Maheshwari, A. Rungta Sawai. Man 
Singh Medical Collge, Jaipur, India 
22 385 serum samples have been tested for HIV antibodies between 
1987 and September 1998 at the HIV Surveillance Centre housed in 
the Department of Microbiology and Immunology. Categories of 
subjects include: STD patienk, foreign students, indoor patients with 
suspected AIDS from the SMS and attached group of hospitals, ante- 
natal mothers, blood donors, etc. 441 samples in this study have been 
found seropositive by ELISA coupled with a supplementary test like 
Immunocomb/HIV spot/another ELISA. 340 of these 2ERS-posi- 
tive samples were further confirmed by Western blot, while 2 
remained indeterminate. The remaining 99 samples include: W B  
confirmation report awaited, W B  negative, pre-WB repeat ELISA 
negative and WB not performed since samples inadequate/turbid/ 
hemolyzed or blood donor samples. HIV 2 alone was detected in 2 
samples and HIV 1 and 2 in another 13. 
Sharp rising trends are noticeable in the HIV seropositivity over 
the last 4 years, the percentage graph showing a steep incline. These 
are: 2.56% (1994), 5.79% (1995), 6.86% (19961, 12.2% (1997) and 
14.59% (9 months of 1998). 
I P285 I Managing diarrheas during HIV infection in 
Senegal 
A. Aidara-Kane', P.S. Sow', A. GuPye-Ndiaye', E Fall4, I? 
Caniara4, l? Hovette4, E Klotz4, B. Sambs, S. M'boup3. 'Instirut 
Pasteur, Dakar, zCHU Fann, Dakar, 'CHU Le Dantec, Dakar, 
'Hopital Principal, Dakar, SCnbgaXal; 'ZNSERM U88, Saint-Maurice, 
France 
Objectives: We conducted a case-control study in S&gal among 
HIV-seropositive (HIV+) and seronegative (HIV-) subjects to iden- 
ti$ major types and prevalences of enteric pathogens in adult 
patients, and patterns of resistance to antibiotics, with the aim of 
providing guidance to physicians for case management. 
Methods: Bacterial pathogens, parasites and fungi were identified 
by conventional methods and P C R  (different E. roli pathotypes). 
Opportunistic parasites such as Cryptosporidium and Microsporidium 
were identified by Kinyoun method and trichromic stain of Weber 
respectively. Rotavirus was identified with a commercial latex agglu- 
tination kit. 
Results: The nature and etiologies of diarrheas were different 
according to HIV serostatus and CD4 cells. Shigella and Salmonella 
were the most frequently identified agents in HIV patients in acute 
diarrheas. Among HIV+ patients, persistent diarrhea was more 
frequently observed and was often associated with opportunistic para- 
sites such as Cryprosporidium (9.1%), Blasrocystis hominis (8.0%), 
Microspuridiicm (6.7%) and bacteria as enteroaggregative Esrherichia cuii 
(9.1 %). Strict pathogens such as Saimonefla, Sh&lla and rotavirus were 
also isolated in HIV+ patients but they were associated with acute 
diarrheas. Candida albicans was considered as a potential enteric 
pathogen in HIV+ patients with very low CD4 counts (<80/mm3) 
because it was isolated in 4 cases of chronic diarrhea as sole pathogen. 
Conclusions: Taking these results in consideration, 5 different 
algorithms were proposed for the management of diarrhea during 
HIV infection in Senegal. 
lp2861 Microbiological study of liver biopsies in HIV+ 
patients 
T.J. Pacheco, M.M. Viana, A. Gi1, E Borges, C. Araujo, M. 
Viveiros, K. Mansinho. Microbiology Department, Infectious Diseases 
Department Hospital de Egas Mowiz, Inst. Hyg. Med. Eop, Lisbon, 
Portugal 
Objectives: To evaluate the utility of microbiological study of 
percutaneous liver biopsy in HIV+ patients with prolonged fever and 
with or without liver enlargement. 
Methods: Between January 1995 and September 1998, we under- 
took mycologic, parasitologic, bacteriologic and mycobacteriologic 
investigations in 144 liver biopsies taken from 144 HIV. patients. 
We performed direct examination after staining by the Gram, 
Ziehl-Neelsen, and Giemsa methods. Cultures were performed in 
blood agar, Sabouraud dextrose agar, Todd-Hewitt broth enriched 
with blood, trypticase soy broth, Lowenstein-Jensen medium, and 
Novy-MacNeal-Nicolle medium. Microorganism identification was 
done by conventional methods. 
Results: The etiologic agent was identified in 34 patients (23.6%). 
In 27 ofthese, (18.75% of the total population) the implicated organ- 
isms were Mycobacterium spp., in 3 (2.1%) Leishmania spp., in 2 (1.4%) 
Nocardia spp., in 1 (0.7%) Rhodococcus 'p. And in 1 Cryprococcus sp. 
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Conclusions: The dissemination of niycobacteria (among other 
infectious agents) is not always diagnosed in the biological speciinens 
frequently submitted for laboratory investigation, namely blood and 
bone marrow. The percentage of etiologic diagnoses of disseminated 
opportunistic infections obtained in this study (23.6%) and the speed 
with which the diagnosis can be obtained by direct examination stress 
the need for invasive (but promising) methods such as percutaneous 
liver biopsy for the diagnosis of disseminated infections of various 
etiologies when the level of suspicion is high. 
lp2871 Ocular tuberculosis in AIDS patients 
M.M. Viana', T.J. Pacheco', C. Araujo', F. VaZ3, A. Gill, J. Nina2, 
H.  Rita', K. Mansinho'. l.bficrobiulua, 'Department oflnfectiuus 
Diseases, - 3 D ~ i ~ a r ~ m i , n t  of Ophtalniulu,~!qy, Hospital de Egas Moiiiz, 
k b o n ,  Portirga/ 
Background and objectives: Disseminated tuberculosis involving 
various organs and systems is a frequent opportunistic infection in 
HIV+ patients. The niycobacteriologic diagnosis is sometimes difi- 
cult, due to the unspecific syniptonis and uncommon localization. 
Our purpose IS to relate two clinical cases of ocular tuberculosis in 
AIDS patients, diagnosed by observation of alcohol-acid-fast bacilli 
in the conjunctival exudate, the bacilli having been identified as 
Myrubacteriir~i ttrbercitlosis complex by conventional methods. 
Observations: The first case occurred in a male patient, addicted 
to intravenous narcotics, HIVl+,  with a level of 60 CD4+ lynipho- 
cytes/mm'. Our patient presented with panophtaimitis during the 
course of treatment with antibacillary agents, which he did not 
accomplish with regularity. Three and a half months previously, he 
had been diagnosed as having pulmonary and lymph node tubercu- 
losis. The strain of Mpbac t r r ium tuberculosis complex isolated from 
the ocular exudate was resistant to isoniazid, rifampin, streptomycin 
and ethambutoi. Before knowledge of antimicrobial sensitivity test 
results, the patient was medicated empirically with amikacin, clar- 
ithromycin and pyrazinamide, in addition to the first-line antibacil- 
lary agents. In spite of this, he developed a picture of meningitis 
leading to coma and subsequent death. 
Our second patient was an HIV2+ heterosexual male with a level 
of 66 CD4+ lyiiiphocytes/mm'. He presented with episcleritis in a 
context of fever, weight loss, nocturnal sudoresn, and pleuritic pain. 
Chest X-ray demonstrates a left pleural effusion in small quantity. The 
abdominal echography showed a splenic image which suggested the 
presence of microabcesses. Laboratory investigation for the diagnosis 
of niycobactcriosis was negative in sputum, in cultures of blood and 
bone marrow, and in liver biopsy The isolation and identification of 
Mycubacteriunt tirberculusis complex was only achieved from conjunc- 
tival exudate. The strain was susceptible to isoniazid, rifanipin, and 
ethambutol, and resistant to streptomycin only. The patient became 
apyretic on the fourth day of therapy with first-line antibacillary 
agents. He was discharged, with a favorable evolution at follow-up. 
Conclusions: Although rare and sporadic, the ocular localization 
of tuberculosis should be considered in patients infected by H.I.V. , 
either with confirmed disseminated tuberculosis or with the diag- 
nostic suspicion of tuberculosis. This is especially true for narcotic- 
addicted patients who do not regularly accomplish the prescribed 
antituberculous therapy 
lp2881 Microsporidiosis in respiratory samples of an 
HIV+ patient 
T.J. Pacheco', M.M. Viana', A. Gill, A. Galiano?, E Nogueira'. 
'Micrubiology Departnzent, 'Infectious Diseases Department, 'Pneunzolofy 
Department', 'Hospital de Egas Moniz; 'Hospital SnoJooao de Ileus, 
Lisbon, Portu<qai 
Background: Infection by protozoa of the order Microsporidia is 
an increasingly important parasitosis in AIDS patients (a 5-30%1 inci- 
dence in this population being reported in the literature). Thrce 
obligate intracellular parasites most commonly induce a picture of 
chronic diarrhea, the causative organisms being demonstrated in small 
intestine biopsy specimens. Extraintestinal ditcemination more 
frequently manifests itself as cholangitis or cholecystitic; respirator): 
tract infection is infrequently reported. 
Case: A 32-year-old male patient was admitted to our hospital in 
April 1998 with productive cough, fever (peaking at 39°C). weight 
loss and epigastric pain. He was addicted to intravenous narcotics and 
known since 1995 to be HIVI', with a previous diagnosis (1997) of 
pulmonary and cervical lymph node tuberculosis. Chest X-ray 
showed hilar engurgitation and reinforcement of pulmonary reticu- 
lum. Abdominal echography showed a slight liver enlargement 
suggestive of hepatitis. Laboratory data included leucopenia (with 7 
CD4+ lymphocytes/ mL) and relative hypoxemia 011 blood gas 
analysis. 
Bronchofibroscopy followed by bronchoalveolar lavage was 
performed. Cram-negative organisms with morphologic characteris- 
tics of the order Microsporidia were observed in bronchial secretions. 
An 8-day course of albendazole (400 mg b i d .  PO) was prescribed, 
at the end of which bronchial secretions, bronchoalvcolar lavage fluid 
and biopsy tissue of the bronchial niucosa were negative fbr 
microsporidian protozoa. The patient had become apyretic after the 
beginning of therapy, and was discharged with clinical improvement. 
Conclusions: Improvement of symptoms accompanied by appar- 
ent eradication of the parasite froni the respiratory tree in this c ~ s e  
suggests that the physician should be aware of the potential of 
microsporidian protozoa to cause pulmonary discase in imniunosup- 
pressed patients, even in the absence of obviou5 enterologic involve- 
ment. 
lm Cerebrospinal fluid free light chains in patients 
with toxoplasmic encephalitis 
C. Contiiii', 'E. Fainardi', R. Cultrera', S. Seraceni', V. Monda', 
M. Castellazzi*, E. Granieri'. 'Department of Clirzical G E x p e r i m e d  
Medicine, Infctiuus Diseases, 'Department of- Nctiroloqy, ~Jtrii~ersrty of
Ferrara, Ferrara, Italy 
Objectives: Based on prior reports of qpecific anti-7: gondii oligo- 
clonal IgG (OCB- IgG) bands in the CSF of AIDS patients with 
toxoplasmic encephalitis (TE). we evaluated the immunoglobulin 
light chain composition (types kappa and lambda) of OCB-IgG from 
patients with and without TE. 
Methods: Free light chain (FLC kappa and lambda) content was 
determined in paired serum and CSF saniples from three patient 
groups: (a) 6 with presumptive and untreated TE (clinical and C T  
scans, positive serology and P C R  assay), (b) 10 with other neurologic 
inflammatory disorders, and (c) 14 neurologicly healthy control indl- 
viduals. CSF FLC were determined by an affinitymediated capillary 
blotting technique (AMI) after isoelectric focusing in agarose gel. 
Results: Elevated kappa FLC were detected in CSF samples from 
9/15 TE patients who had displayed unique CSF-rectricted IgG 
OCB (local synthesis, 8 cases) or an oligoclonal systemic antibody 
response with identical OCB in serum and CSF (mirror pattern, 1 
162  Cl in ica l  M i c r o b i o l o g y  and In fec t ion ,  Vo lume 5 Supp lement  3 
case). The kappa FLC were undetectable in most controls. Only one 
TE CSF exibited band staining for lambda FLC alone. FLC were not 
detected in matched serum samples. 
Conclusions: These results suggest that the activation of the 
immune system occurs early in patients with TE. This study also 
showed that (1) intrathecal production of CSF FLC and IgG synthe- 
sis are closely associated, and (2) that the intrathecal FLC detection 
was predominantly kappa rather than lambda. This can be taken as a 
marker of an ongoing toxoplasmic infection within the CNS. 
w/ Clostridium difficile infections in HIV-positive 
patients 
S. Wongwanich, S. Ramsiri, M. Kusum, P. Warachit. National 
Institute ofHealth, Nonthaburi, Thailand 
Objectives: To investigate the prevalence of Clostridium dficile infec- 
tions in HIV-positive patients with regard to the presence of its 
enterotoxin. 
Methods: Enzyme immunoassay (EIA, Meridian Diagnostic Inc.) 
was used for the detection of C. d@cile enterotoxin in stool speci- 
mens collected from 201 HIV-positive and 271 HIV-negative diar- 
rheal patients. Culture was performed on cycloserine cefoxitin 
fructose agar. Chromosomal DNA types of C. d@cile isolates were 
determined by pulsed-field gel electrophoresis (PFGE). 
Results: In the HIV-positive group, C. d@cile enterotoxin was 
found in 58.8% and 13.2% of diarrheal and non-diarrheal patients, 
respectively, whereas this toxin was found in 36.5% of HIV-negative 
diarrheal .patients. However, 13.6% of stool samples were negative by 
toxin assay, but were positive for C. dficile by culture and latex agglu- 
tination test. All C. d@cik isolates were susceptible to vancomycin. 
Teicoplanin was about four times more potent than vancomycin. 
Among isolates from both HIV-positive and HIV-negative patients, 
six patterns of PFGE type-A, B, C, D, E and F-were observed. 
Conclusions: This study demonstrated the higher rate of C. d@- 
cile diarrhea detected in HIV-positive patients in comparison to the 
general population in a developing country. 
(p291) A survey of serratia marcescens infection in 
patients hospitalized for HIV disease 
R. Manfredi, K. Nanetti, M. Ferri, E Chiodo. Department .f 
Clinical G Experimental Medicine, University o f  Bologna, Italy 
Objectives: To evaluate the role of S. maicestem (Sm) complications 
in the setting of HIV disease. 
Methods: A review of clinical charts of 2400 consecutive HIV- 
infected patients (p) hospitaltzed since 1991 was made. 
Results: 17 p of 2400 (0.7%) aged 23-49 years (9 IV drug users, 
5 homosexuals, 3 heterosexuals) developed Sm sepsis (9 p), pnen- 
monia (6 p), and lymph node and decubitus ulcer infection (1 p each. 
Our p had a mean CD4+ lymphocyte count of 69.5 ?2 1.4/pL, 
while a neutrophil count <15OO/pL was present in 12 p of 17; 13 
p had a prior diagnosis of AIDS. Sm disease occurred after the first 
72 h of admission in 11 p of 17, but a central IV line was present in 
only 2 p. During the month preceding disease onset, 10 and 5 p took 
antibiotics or corticosteroids respectively, while 12 p were given 
cotrimoxazole treatment or prophylaxis. In vitro susceptibility assays 
showed a 100% resistance to ampicillin and cephalothin, while 
83.4-94.1% of isolates tested sensitive to piperacillin, cefotaxime, 
aminoglycosides, qumolones, and cotrimoxazole; one strain tested 
multiresistant, but remained susceptible to imipenem. AU p received 
a 6-14-day course of antibiotics (mostly third-generation 
cephalosporins plus aminoglycosides), and obtained clinical and 
microbiological cure, in the absence of related mortality or disease 
relapses. 
Conclusions: Sm is an emerging pathogen causing sepsis and 
respiratory or urinary tract infections in p with underlying diseases, 
above all when hospitalization and instrumentation are of concern. 
Only 15 cases of Sm complications have been described in HIV- 
infected p since 1987, in 9 different reports: 7 p with pneumonia, 5 
with sepsis, and one case each of endophthalmitis, perifolliculitis, and 
cholecystitis. Therefore, our series of HIV-associated Sm disease is 
the largest reported to date: a broad spectrum of localizations, a rela- 
tionship with advanced HIV disease, a low CD4+ cell count, 
neutropenia, hospitalization, and prior antibiotic use was shown. 
Bacterial isolates showed a better sensitivity profile than expected, so 
that all p were cured, with limited consequences for HIV disease 
course. 
[p292) Pseudomonas complications in the setting of 
HIV disease: a comparison of hospital- and 
community-acquired disease 
R. Manfred, A. Nanetti, M. Ferri, E Chiodo. Department of 
Clinical G Experimental Medicine, University .f Bologna, Ztaly 
Objectives: To compare the clinical and microbiological profile of 
hospital- and community-acquired pseudomonas infection in 179 
consecutive HIV-infected patients (p) hospitalized since 1991, 
Methods: Disease features of 104 episodes of pseudomonas 
complications that occurred at least 72 h after admission (nosocomial 
infection) were compared with those of 110 episodes of community- 
acquired infection. 
Results: Pseudomonas disease involved lower airways (66 cases), 
urinary tract (53 episodes), and blood (34 cases), with I? aeruginora 
isolated in 161 episodes, and other Pseudomonas spp. in 63 cases; 
20.7% of p experienced relapses (45 overall episodes). A mean CD4 
cell count of51.8+22.1/pL was found, and a prior diagnosis ofAIDS 
and neutropenia was also common. Indwelling IV and urinary 
catheters were significantly associated with bacteremia and urinary 
tract involvement, respectively. More than 60% of p were given 
antibiotics or cotrimoxazole in the month preceding disease onset. 
At least 80% of bacterial isolates tested susceptible to piperacillin, 
ceftazidime, imipenem, aminoglycosides, and quinolones. Anti- 
microbial therapy cured 73.2% ofp at the primary episode, and 22.3% 
more p after one or more relapses. A lethal outcome occurred in 8 
p (4.5%) with an advanced HIV disease and neutropenia. Nosocomial 
disease (compared with a community-acquired one) proved signifi- 
cantly related to a diagnosis of AIDS (p<O.OOl), a neutrophil count 
< lOOO/pL (p 0.01), sepsis-bacteremia (p<0.003) or urinary tract 
involvement (p 0.001), disease relapses (p<O.OOl),  the isolation of 
non-aeruginosa Pseudomonas spp. (p 0.001), and death @<0.03). 
Conclusions: Prior surveys of HIV-associated pseudomonas 
complicahons showed great variation in predisposing factors, and rate 
of hospital-acquired disease. Our experience confirms that 
Pseudomonas organisms are responsible for remarkable morbidity and 
mortality during HIV infection, especially when nosocomial in 
origin. The evaluation of epidemiology and risk factors of HIV- 
related pseudomonas disease may help in defining specific manage- 
ment strategies. 
A b s t r a c t s  1 6 3  
[ E l  Flavobacterium spp. infection in patients with 
advanced HIV disease 
R. Manfredi', A. Naiietti', M. Ferri', A. Mastroiann?, 0. 
Coronado', E Chiodo'. 'Department of Clinical G Experimental 
LWediciiie, University .f Bolucq!qna, Bolofna, 'Division .f Inffctious 
Diseasa, 'G.B. Moya,qnr' Hospital, Forli, Italy 
Objectives: Six cases of HIV-associated FIauobacterirrm spp. sepsis and 
pneumonia are described. 
Case reports: In a 6-year period, 6 patients (p) hospitalized for 
advanced HIV disease (4 homosexuals and 2 heterosexual females, 
aged 26-40 years) developed Flauobacterium spp. sepsis (5 cases) or 
pneumonia (1 p). Blood cultures yielded pure E meninpept icum and 
Nauo6aiterium spp. in 2 cases each, and E odoratum in 1 p, while in 1 
p with pneumonia, Flavobacterium spp. were isolated from bronchial 
aspirate. All p had a prior diagnosis of AIDS arid a severe immunod- 
eficiency, with a mean CD4+ lymphocyte count of 64.21: 11.9/pL, 
and a mean neutrophil count of 1043?216/pL. However, only 3 
cases of 6 were nosocomial in origin (since recognized after the third 
day of admission), and no p underwent prior instrumentation. Broad- 
spectrum antibiotics and cotriiiioxazole prophylaxis had been carried 
out in the month preceding hospitalization by 2 and 5 p, respectively. 
According to a broth microdilution assay, all strains tested sensitive to 
ciprofloxacin, 3 of 6 to piperacillin, ticarcillin-clavulanate, ceftazidime, 
itnipenem and gentamkin, 2 to mezlocillin, tobramycin, and 
amikacin, and one to aztreonani. After a 7-13-day course of iv 
ciprofloxacin, imipenem, piperacillin or ceftazidime, all p had a favor- 
able outconie, with no related mortality or relapses. 
Conclusions: Flauobacterium spp. organisms are Gram-negative 
oxidase-positive bacilli commonly isolated from environmental 
sources, but infrequently responsible for human disease. Apart from 
early described neonatal meningitis, sepsis (often catheter-related). 
pneumonia, and rarely endocarditis, cellulitis, and intra-abdominal 
and surgical infection have been reported in hospitalized p with 
severe underlying diseases (cancer, diabetes mellitus, burns, and 
chronic hematologic or kidney disorders), or with concurrent 
neutropenia or instrumentation. However, only one case of HIV- 
related lethal E multivontm sepsis has been described in a p with 
concurrent diabetes niellitus (J Med Assoc Thai 1996; 79: 395). 
Flavibacterium spp. organisms should be considered as nosocomial- or 
community-acquired opportunistic pathogens even in p with HIV 
disease, due to their relationship with deep immunodeficiency and 
their elevated resistance to many antimicrobial agents commonly used 
against Gran-negative bacterial infections. 
Pediatric infections including vaccination I 
Bordetella pertussis infection: study of 78 
cases 
A. Goinez, C. Prior, MJ. Uria, A. Rico, A. Garcia-Perea. 
Departrnerrt ofkficrohiology 'LA Paz' Hospital, Madrid, Spain 
Objectives: To analyze the epidemiologic features of pertussis in our 
area. 
Methods: Between 1991 and 1998, 78 cases of B. pertussis infec- 
tion were confirmed by the culture of nasopharyngeal aspirates. 
Samples were placed on charcoal agar supplemented with defibri- 
nated horse blood and cefalexine (Oxoid, incubated at 35°C in a 
humid atmosphere). Identification of isolates was biochemically veri- 
fied by testing catalase, oxidase and agglutination with specific anti- 
sera (Difco). Patients were emergency cases or admitted to the prdi- 
atric ward. 
Results: We studied the background of 34 patients. 100%~ had 
paroxysmal cough, 50% whooping couch, 24% vomiting, 53% 
cyanosis and 100% lymphocytosis. Tables 1 and 2 show the seasonal, 
age and gender distribution. 
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During this period incidence ranged between 5%) and 27%. 
Conclusions: Seasonality of infection with B. pertussis has been 
observed, generally coinciding with spring and summer. It occurs 
more often in boys and among infants younger than 4 months. 
lp295) The efficacy of ceftibuten in 5- versus 10-day 
treatment of recurrent acute otitis media in 
children 
K. Roos', P. Larssod, a Swedish Study Group. ' E N T  Department, 
Lundby Hospital, 'Departmetit of Irq2ctiou.y Diseases, S u l r [ p i s k a  
University Hospital, Cstra, GOte605~, Sweden 
Objectives: To compare the eficacy of 5 versus 10 days of treatinent 
in recurrent acute otitis media (AOM). 
Methods: Outpatients with a new clinical AOM within 1 inonth 
were randomized to 5 or 10 days of treatment with ceftibuten 9 
mg/kg/day ac a single dose. 
Results: The mean age of the patients was 1.2 years. They had 
on average had 3 AOM during the precedmg 12 month$. The recur- 
rence rates in the 5- and 10-day treatment group were 21.4% and 
4.5% respectively at first follow-up visit on day 14 (p=0.001). This 
difference was most clearly seen in children less than 2 years. 
The total recurrence rates during the whole follow-up period of 
40 days, 35.0%) and 30.0% respectively, did not differ sibmificantly 
Pneumococci with decreased susceptibility to penicillin were found 
in 5% and beta-lactamase-producing Hacrnophilcls irg'lirenzae in 8'% of 
nasopharyngeal cultures. 
Conclusions: A 10-day treatment with ceftibuten in recurrent 
AOM is significantly superior to a 5-day course at early follow-up. 
However, after the whole follow-up period this difference between 
the two treatment groups could not be seen. 
I P296 I Otitis media-related antibiotic prescription and 
outcomes in children 
P. Marchisio, S. Esposito, T. Oldoni, N. Principi. Pediatric 
Deppartment IV L. Sacco Hospital, University q f M i / a t i ,  Milan, I t d y  
Objectives: To assess the clinical efficacy of antibiotics prescribed as 
first-line therapy for acute otitis media (AOM) and the microbiolog- 
ical survey of the middle ear fluid (MEF) culturec in patients with 
AOM who have failed antibiotic treatment. 
Methods: Italian children aged between 3 months and 12 years, 
who had a clinical dlagnosis of AOM and who received their first 
antibiotic for their current episode of AOM, were studied. The clin- 
